Surgical Research Fellowship
Posted: 19th of June, 2019
Master of Philosophy or PhD research program (Hepato-Biliary cancer)
Expressions of Interest
The Northern Upper GI Surgery Unit (Royal North Shore Hospital and North Shore Private Hospital, Sydney) is offering a funded full-time research position in HPB surgery for a 12- month period, with a view to extension. This is open to candidates currently enrolled in a surgical training program or who have just completed surgical training. The candidate must have Australian citizenship and hold current registration with AHPRA.
This is a time-limited research experience providing exposure to both clinical and laboratory research. It is an ideal opportunity to be supervised and mentored by experienced researchers and clinicians. Candidates will have an opportunity to prepare and submit manuscripts for peer-reviewed publication. Enrolment in the Master of Philosophy program is for 2 years, with a possibility of converting to a PhD degree if desired. (https://sydney.edu.au/courses/courses/pr/master-of-philosophy-medicine.html)
The ideal candidate should be a Royal Australasian College of Surgeons surgical trainee SET 3 or above or be a new Fellow within the first two years following award of their FRACS. More junior candidates who are not yet on the program will also be considered depending on their application. Candidates should demonstrate an interest and experience in some form of research, as well as an ability for self-directed project management. Successful applicants can expect substantial stipend support for the first year of candidature as well as opportunities for surgical assisting, with the expectation to apply for competitive grants and scholarships going forward.
The Northern HPB unit has a proven track record of strong clinical and laboratory research and benefits from a large prospectively maintained liver resection database, a large liver tumour biobank, and strong affiliations with basic scientists in the RNSH Kolling Institute.
Research program opportunities include (but are not limited to):
- Investigating molecular features of colorectal liver metastasis
- (whole exome sequencing, nanostring gene expression profiling and proteomic expression analysis)
- Identifying early and prognostic biomarkers in liver cancers
- Investigating tumour-stroma interactions in primary and secondary liver cancers
Professor Thomas J Hugh